↓ Skip to main content

Clinical outcomes of switching to aflibercept using a pro re nata treatment regimen in patients with neovascular age-related macular degeneration who incompletely responded to ranibizumab

Overview of attention for article published in BMC Ophthalmology, January 2018
Altmetric Badge

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
22 Mendeley